Calamos Advisors
CORZ icon

Calamos Advisors’s Core Scientific CORZ Stock Holding History

Calamos Advisors’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100,030
Closed -$1.41M – 919
2024
Q4 		$1.41M Buy
+100,030
New +$1.48M 0.01% 640
2024
Q3 		– Sell
-31,612
Closed -$294K – 952
2024
Q2 		$294K Buy
+31,612
New +$161K ﹤0.01% 748

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
GC
Gullane Capital Memphis, Tennessee $37.4M AUM 112.18% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $668M AUM 45.71% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
JCM
JAT Capital Management Greenwich, Connecticut $59.3M AUM 134.04% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return

Calamos Advisors's CORZ Position: Q1 2025 in Review

Calamos Advisors sold out of Core Scientific (CORZ) in Q1 2025, closing a stake of 100,030 shares — an estimated $1.41M sold.

Calamos Advisors first reported a position in CORZ in Q2 2024 and held it in 2 quarters. The position peaked at $1.41M in Q4 2024. 336 funds tracked by Wall St. Rank hold CORZ as of Q1 2025.

  • Calamos Advisors reported no remaining Core Scientific position as of Q1 2025 after selling out during the quarter.
  • Calamos Advisors sold 100,030 Core Scientific shares in Q1 2025, an estimated $1.41M.
  • Calamos Advisors first reported a position in Core Scientific in Q2 2024 and held it in 2 quarters.
  • Calamos Advisors's Core Scientific position peaked at $1.41M in Q4 2024.
  • 336 funds tracked by Wall St. Rank held Core Scientific as of Q1 2025.

Based on Calamos Advisors's 13F filing for Q1 2025, filed 29 Apr 2025.